Global Immuno-oncology Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2030

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Immuno-oncology Therapy
    1.2 Classification of Immuno-oncology Therapy by Type
        1.2.1 Overview: Global Immuno-oncology Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Immuno-oncology Therapy Revenue Market Share by Type in 2020
        1.2.3 Monoclonal Antibodies
        1.2.4 Immune Checkpoint Inhibitors
        1.2.5 Immune System Modulators
        1.2.6 Cancer Vaccines
    1.3 Global Immuno-oncology Therapy Market by Application
        1.3.1 Overview: Global Immuno-oncology Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Center
        1.3.4 Others
    1.4 Global Immuno-oncology Therapy Market Size & Forecast
    1.5 Global Immuno-oncology Therapy Market Size and Forecast by Region
        1.5.1 Global Immuno-oncology Therapy Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Immuno-oncology Therapy Market Size by Region, (2016-2021)
        1.5.3 North America Immuno-oncology Therapy Market Size and Prospect (2018-2030)
        1.5.4 Europe Immuno-oncology Therapy Market Size and Prospect (2018-2030)
        1.5.5 Asia-Pacific Immuno-oncology Therapy Market Size and Prospect (2018-2030)
        1.5.6 South America Immuno-oncology Therapy Market Size and Prospect (2018-2030)
        1.5.7 Middle East and Africa Immuno-oncology Therapy Market Size and Prospect (2018-2030)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Immuno-oncology Therapy Market Drivers
        1.6.2 Immuno-oncology Therapy Market Restraints
        1.6.3 Immuno-oncology Therapy Trends Analysis
2 Company Profiles
    2.1 Amgen
        2.1.1 Amgen Details
        2.1.2 Amgen Major Business
        2.1.3 Amgen Immuno-oncology Therapy Product and Solutions
        2.1.4 Amgen Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.1.5 Amgen Recent Developments and Future Plans
    2.2 AstraZeneca
        2.2.1 AstraZeneca Details
        2.2.2 AstraZeneca Major Business
        2.2.3 AstraZeneca Immuno-oncology Therapy Product and Solutions
        2.2.4 AstraZeneca Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.2.5 AstraZeneca Recent Developments and Future Plans
    2.3 Bristol-Myers Squibb
        2.3.1 Bristol-Myers Squibb Details
        2.3.2 Bristol-Myers Squibb Major Business
        2.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Product and Solutions
        2.3.4 Bristol-Myers Squibb Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.4 Eli-Lilly
        2.4.1 Eli-Lilly Details
        2.4.2 Eli-Lilly Major Business
        2.4.3 Eli-Lilly Immuno-oncology Therapy Product and Solutions
        2.4.4 Eli-Lilly Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.4.5 Eli-Lilly Recent Developments and Future Plans
    2.5 Roche
        2.5.1 Roche Details
        2.5.2 Roche Major Business
        2.5.3 Roche Immuno-oncology Therapy Product and Solutions
        2.5.4 Roche Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.5.5 Roche Recent Developments and Future Plans
    2.6 GlaxoSmithKline
        2.6.1 GlaxoSmithKline Details
        2.6.2 GlaxoSmithKline Major Business
        2.6.3 GlaxoSmithKline Immuno-oncology Therapy Product and Solutions
        2.6.4 GlaxoSmithKline Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.6.5 GlaxoSmithKline Recent Developments and Future Plans
    2.7 Janssen Biotech
        2.7.1 Janssen Biotech Details
        2.7.2 Janssen Biotech Major Business
        2.7.3 Janssen Biotech Immuno-oncology Therapy Product and Solutions
        2.7.4 Janssen Biotech Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.7.5 Janssen Biotech Recent Developments and Future Plans
    2.8 Merck
        2.8.1 Merck Details
        2.8.2 Merck Major Business
        2.8.3 Merck Immuno-oncology Therapy Product and Solutions
        2.8.4 Merck Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.8.5 Merck Recent Developments and Future Plans
    2.9 Novartis
        2.9.1 Novartis Details
        2.9.2 Novartis Major Business
        2.9.3 Novartis Immuno-oncology Therapy Product and Solutions
        2.9.4 Novartis Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.9.5 Novartis Recent Developments and Future Plans
    2.10 Pfizer 
        2.10.1 Pfizer Details
        2.10.2 Pfizer Major Business
        2.10.3 Pfizer Immuno-oncology Therapy Product and Solutions
        2.10.4 Pfizer Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.10.5 Pfizer Recent Developments and Future Plans
    2.11 Sanofi
        2.11.1 Sanofi Details
        2.11.2 Sanofi Major Business
        2.11.3 Sanofi Immuno-oncology Therapy Product and Solutions
        2.11.4 Sanofi Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.11.5 Sanofi Recent Developments and Future Plans
    2.12 Spectrum Pharmaceuticals
        2.12.1 Spectrum Pharmaceuticals Details
        2.12.2 Spectrum Pharmaceuticals Major Business
        2.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Product and Solutions
        2.12.4 Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.12.5 Spectrum Pharmaceuticals Recent Developments and Future Plans
    2.13 Takeda
        2.13.1 Takeda Details
        2.13.2 Takeda Major Business
        2.13.3 Takeda Immuno-oncology Therapy Product and Solutions
        2.13.4 Takeda Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.13.5 Takeda Recent Developments and Future Plans
    2.14 BioNTech SE
        2.14.1 BioNTech SE Details
        2.14.2 BioNTech SE Major Business
        2.14.3 BioNTech SE Immuno-oncology Therapy Product and Solutions
        2.14.4 BioNTech SE Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.14.5 BioNTech SE Recent Developments and Future Plans
    2.15 Allogene Therapeutics
        2.15.1 Allogene Therapeutics Details
        2.15.2 Allogene Therapeutics Major Business
        2.15.3 Allogene Therapeutics Immuno-oncology Therapy Product and Solutions
        2.15.4 Allogene Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.15.5 Allogene Therapeutics Recent Developments and Future Plans
    2.16 IMAB-I-Mab Biopharma Co., Ltd.
        2.16.1 IMAB-I-Mab Biopharma Co., Ltd. Details
        2.16.2 IMAB-I-Mab Biopharma Co., Ltd. Major Business
        2.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product and Solutions
        2.16.4 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.16.5 IMAB-I-Mab Biopharma Co., Ltd. Recent Developments and Future Plans
    2.17 Arcus Biosciences
        2.17.1 Arcus Biosciences Details
        2.17.2 Arcus Biosciences Major Business
        2.17.3 Arcus Biosciences Immuno-oncology Therapy Product and Solutions
        2.17.4 Arcus Biosciences Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.17.5 Arcus Biosciences Recent Developments and Future Plans
    2.18 Gritstone Oncology
        2.18.1 Gritstone Oncology Details
        2.18.2 Gritstone Oncology Major Business
        2.18.3 Gritstone Oncology Immuno-oncology Therapy Product and Solutions
        2.18.4 Gritstone Oncology Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.18.5 Gritstone Oncology Recent Developments and Future Plans
    2.19 Autolus Therapeutics
        2.19.1 Autolus Therapeutics Details
        2.19.2 Autolus Therapeutics Major Business
        2.19.3 Autolus Therapeutics Immuno-oncology Therapy Product and Solutions
        2.19.4 Autolus Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.19.5 Autolus Therapeutics Recent Developments and Future Plans
    2.20 Rubius Therapeutics
        2.20.1 Rubius Therapeutics Details
        2.20.2 Rubius Therapeutics Major Business
        2.20.3 Rubius Therapeutics Immuno-oncology Therapy Product and Solutions
        2.20.4 Rubius Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.20.5 Rubius Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Immuno-oncology Therapy Revenue and Share by Players (2021-2023)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Immuno-oncology Therapy Players Market Share
        3.2.2 Top 10 Immuno-oncology Therapy Players Market Share
        3.2.3 Market Competition Trend
    3.3 Immuno-oncology Therapy Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Immuno-oncology Therapy Revenue and Market Share by Type (2016-2021)
    4.2 Global Immuno-oncology Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Immuno-oncology Therapy Revenue Market Share by Application (2016-2021)
    5.2 Immuno-oncology Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Immuno-oncology Therapy Revenue by Type (2018-2030)
    6.2 North America Immuno-oncology Therapy Revenue by Application (2018-2030)
    6.3 North America Immuno-oncology Therapy Market Size by Country
        6.3.1 North America Immuno-oncology Therapy Revenue by Country (2018-2030)
        6.3.2 United States Immuno-oncology Therapy Market Size and Forecast (2018-2030)
        6.3.3 Canada Immuno-oncology Therapy Market Size and Forecast (2018-2030)
        6.3.4 Mexico Immuno-oncology Therapy Market Size and Forecast (2018-2030)
7 Europe by Country, by Type, and by Application
    7.1 Europe Immuno-oncology Therapy Revenue by Type (2018-2030)
    7.2 Europe Immuno-oncology Therapy Revenue by Application (2018-2030)
    7.3 Europe Immuno-oncology Therapy Market Size by Country
        7.3.1 Europe Immuno-oncology Therapy Revenue by Country (2018-2030)
        7.3.2 Germany Immuno-oncology Therapy Market Size and Forecast (2018-2030)
        7.3.3 France Immuno-oncology Therapy Market Size and Forecast (2018-2030)
        7.3.4 United Kingdom Immuno-oncology Therapy Market Size and Forecast (2018-2030)
        7.3.5 Russia Immuno-oncology Therapy Market Size and Forecast (2018-2030)
        7.3.6 Italy Immuno-oncology Therapy Market Size and Forecast (2018-2030)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Immuno-oncology Therapy Revenue by Type (2018-2030)
    8.2 Asia-Pacific Immuno-oncology Therapy Revenue by Application (2018-2030)
    8.3 Asia-Pacific Immuno-oncology Therapy Market Size by Region
        8.3.1 Asia-Pacific Immuno-oncology Therapy Revenue by Region (2018-2030)
        8.3.2 China Immuno-oncology Therapy Market Size and Forecast (2018-2030)
        8.3.3 Japan Immuno-oncology Therapy Market Size and Forecast (2018-2030)
        8.3.4 South Korea Immuno-oncology Therapy Market Size and Forecast (2018-2030)
        8.3.5 India Immuno-oncology Therapy Market Size and Forecast (2018-2030)
        8.3.6 Southeast Asia Immuno-oncology Therapy Market Size and Forecast (2018-2030)
        8.3.7 Australia Immuno-oncology Therapy Market Size and Forecast (2018-2030)
9 South America by Country, by Type, and by Application
    9.1 South America Immuno-oncology Therapy Revenue by Type (2018-2030)
    9.2 South America Immuno-oncology Therapy Revenue by Application (2018-2030)
    9.3 South America Immuno-oncology Therapy Market Size by Country
        9.3.1 South America Immuno-oncology Therapy Revenue by Country (2018-2030)
        9.3.2 Brazil Immuno-oncology Therapy Market Size and Forecast (2018-2030)
        9.3.3 Argentina Immuno-oncology Therapy Market Size and Forecast (2018-2030)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Immuno-oncology Therapy Revenue by Type (2018-2030)
    10.2 Middle East & Africa Immuno-oncology Therapy Revenue by Application (2018-2030)
    10.3 Middle East & Africa Immuno-oncology Therapy Market Size by Country
        10.3.1 Middle East & Africa Immuno-oncology Therapy Revenue by Country (2018-2030)
        10.3.2 Turkey Immuno-oncology Therapy Market Size and Forecast (2018-2030)
        10.3.3 Saudi Arabia Immuno-oncology Therapy Market Size and Forecast (2018-2030)
        10.3.4 UAE Immuno-oncology Therapy Market Size and Forecast (2018-2030)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer